Published 1 day ago • loading... • Updated 1 day ago
Bayer faces trial test of remaining Roundup claims after US Supreme Court win
Three cancer patients say Monsanto failed to test Roundup adequately as the case tests whether design-defect claims can survive a Supreme Court ruling.
By Dietrich Knauth NEW YORK, Sept 29 (Reuters) - Attorneys for three cancer patients told a Missouri jury on Tuesday that Bayer's Monsanto unit failed to adequately test its Roundup weedkiller before selling it, starting a trial that could help determi...